Canadian Biomarker Integration Network for Depression (CAN-BIND) - Validation Study
Condition:  Major Depressive Disorder Interventions:  Drug: Escitalopram;  Drug: Brexpiprazole Sponsors:  University Health Network, Toronto;  St. Michael's Hospital, Toronto;  Baycrest;  Centre for Addiction and Mental Health;  McMaster University;  Queen's University;  University of Ottawa;  University of British Columbia;  University of Calgary;  McGill Univ ersity;  Dalhousie University;  University of Michigan;  Simon Fraser University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials